Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Drug Candidates
100,0
%
| 92 | 100,0 % | 90 | 100,0 % | -2,10% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Rest of World
87,3
%
| 82 | 89,3 % | 79 | 87,3 % | -4,35% |
United States
12,7
%
| 10 | 10,7 % | 11 | 12,7 % | +16,66% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Howard Robin
CEO | Chief Executive Officer | 71 | 01/01/07 |
Robert Chess
CHM | Chairman | 66 | 01/12/91 |
Sandra Gardiner
DFI | Director of Finance/CFO | 58 | 17/04/23 |
Chief Tech/Sci/R&D Officer | 49 | 01/07/15 | |
Mary Tagliaferri
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/01/15 |
Vivian Wu
IRC | Investor Relations Contact | - | 01/11/18 |
Robert Bacci
HRO | Human Resources Officer | - | 01/01/01 |
Mark Wilson
LAW | General Counsel | 52 | 01/05/02 |
Jennifer Ruddock
PRN | Corporate Officer/Principal | - | 01/01/04 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
R. Scott Greer
BRD | Director/Board Member | 65 | 01/01/10 |
Roy A. Whitfield
BRD | Director/Board Member | 70 | 01/08/00 |
Robert Chess
CHM | Chairman | 66 | 01/12/91 |
Howard Robin
CEO | Chief Executive Officer | 71 | 01/01/07 |
Jeff Ajer
BRD | Director/Board Member | 61 | 21/09/17 |
Myriam Curet
BRD | Director/Board Member | 67 | 16/12/19 |
Diana Brainard
BRD | Director/Board Member | 53 | 11/11/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 183 617 817 | 182 108 535 ( 99,18 %) | 0 | 99,18 % |
Coordinate società
Nektar Therapeutics
455 Mission Bay Boulevard South
94158, San Francisco
+415 482 5300
http://www.nektar.comSocietà del gruppo
Nome | Categoria e settore |
---|---|
Nektar Therapeutics (India) Pvt Ltd.
Nektar Therapeutics (India) Pvt Ltd. BiotechnologyHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics (India) Pvt Ltd. develops biopharmaceutical products. The private company is based in Hyderabad, India. |
Biotechnology
|
Settore
Vendite per regione
Variaz. 1 gen. | Capi. | |
---|---|---|
+25,83% | 661 Mrd | |
+27,00% | 566 Mrd | |
-6,76% | 352 Mrd | |
+20,34% | 332 Mrd | |
+3,00% | 283 Mrd | |
+13,09% | 231 Mrd | |
+5,46% | 200 Mrd | |
-9,61% | 195 Mrd | |
-6,26% | 145 Mrd |